Media Press Kit

hVIVO, part of Open Orphan plc, is the world leader in the testing of vaccines and antivirals using human challenge study clinical trials and is led by an experienced Leadership team.

Please see some useful resources below including the latest Open Orphan plc investor presentation, approved company descriptions, and images which can be used for editorial purposes as long as the connection to Open Orphan / hVIVO / Venn is clearly recognisable. Commercial use is prohibited.

Visit our Company News page to see more recent Company Announcements and please contact carol.dalton@openorphan.com if you require any further information or wish to schedule an interview.

Presentations

TITLE DATE SIZE DOWNLOAD
Open Orphan Investor Presentation 30.09.20 2.0MB PDF

Images – hVIVO


IMAGE TITLE SIZE DOWNLOAD
Cathal Friel - Executive Chairman Open Orphan plc Cathal Friel – Executive Chairman Open Orphan plc 12.4 MB JPG
Dr Andrew Catchpole - hVIVO Chief Scientist Dr Andrew Catchpole – hVIVO Chief Scientist 6.6 MB JPG
Adam French - hVIVO Director Laboratory Operations Adam French – hVIVO Director Laboratory Operations 9.8 MB JPG
Danny Smith - Director of Volunteer Engagement & Retention Danny Smith – Director of Volunteer Engagement & Retention 9.6 MB JPG
FluCamp Nurse 1 FluCamp Nurse 1 16.7 MB JPG
FluCamp Nurse 2 FluCamp Nurse 2 14.7 MB JPG
FluCamp Nurse 3 FluCamp Nurse 3 20.5 MB JPG
Nurse with sample Nurse with sample 1.5 MB JPG
hVIVO FluCamp hVIVO FluCamp 1 110kb JPG
hVIVO FluCamp 2 hVIVO FluCamp 2 288kb JPG
hVIVO FluCamp 3 hVIVO FluCamp 3 16.1 MB JPG
hVIVO FluCamp 4 hVIVO FluCamp 4 1.6 MB JPG
hVIVO Lab 1 hVIVO Lab 1 20.9 MB JPG
hVIVO Lab 2 hVIVO Lab 2 9 MB JPG
hVIVO Lab 3 hVIVO Lab 3 18.7 MB JPG
hVIVO Lab 4 hVIVO Lab 4 17.2 MB JPG
FluCamp Volunteer 1 FluCamp Volunteer 1 23.2 MB JPG

Company Logos

FILE TITLE SIZE DOWNLOAD
hVIVO Logo hVIVO Logo 29KB PNG
Open Orphan Logo Open Orphan Logo 157KB PNG
Venn Life Sciences Logo Venn Life Sciences Logo 126KB JPG
Flucamp Logo Flucamp Logo 31KB PNG

Approved Company Descriptions

Open Orphan – 75 words

Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe’s only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility. Which offers highly specialised virology and immunology laboratory services to support pre-clinical and clinical respiratory drug, antiviral, and vaccine discovery and development.For more information please visit our Company Overview page

Open Orphan – 150 words

Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe’s only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility. Which offers highly specialised virology and immunology laboratory services to support pre-clinical and clinical respiratory drug, antiviral, and vaccine discovery and development.

The Company has a leading portfolio of 8 viral challenge study models which are: 2 FLU, 2 RSV, 1 HRV, 1 Asthma, 1 cough and 1 COPD viral challenge models. As announced in early March, Open Orphan is rapidly advancing a number of Coronavirus challenge study models and expects to be helping many COVID-19 vaccine development companies to test their vaccines.

Open Orphan comprises of two commercial specialist CRO services businesses (hVIVO and Venn) and is developing an early stage orphan drug genomics data platform business.

For more information please visit our Company Overview page

Press Releases

TITLE DATE SIZE DOWNLOAD
Press Launch of hVIVO COVID Clear Test 04.06.20 267KB PDF